Business
AstraZeneca launches new drug to prevent COVID symptoms – Sydney Morning Herald
The company behind one of Australia’s key COVID-19 vaccines has filed for approval in the US for a drug to fight the virus.
Pfizer launched a study of the drug in 2,660 patients last week. Its treatment is designed as a pill that is taken over five days at the first sign of infection or awareness of exposure to the virus, acting to block the activity of the enzyme the virus…
Continue Reading
-
Business20 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General20 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Noosa News24 hours agoStory Bridge documents released amid cover-up claims
-
General24 hours agoMandatory sentencing reinstated for some DVO breaches in NT after bill passes parliament